nach oben

Erschienen in:

17.06.2022 | Original Article

Anti-seizure medication treatment and outcomes in acute ischemic stroke patients undergoing continuous EEG monitoring

verfasst von: Paula R. Sanches, Mohammad Tabaeizadeh, Lidia M. V. R. Moura, Eric S. Rosenthal, Luis Otavio Caboclo, John Hsu, Elisabetta Patorno, M. Brandon Westover, Sahar F. Zafar

Erschienen in: Neurological Sciences | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the association of anti-seizure medication (ASM) treatment with outcomes in acute ischemic stroke (AIS) patients undergoing continuous electroencephalography (cEEG).

Methods

Retrospective analysis of AIS patients admitted between 2012 and 2019. The following are the inclusion criteria: age ≥ 18 years and ≥ 16 h of cEEG within the first 7 days of admission. ASM treatment exposure was defined as > 48 h of treatment after the first 24 h of cEEG. The primary outcome measure was 90-day mortality, and the secondary outcome was 90-day functional recovery (Modified Ranking Scale 0–3). Propensity scores were used to adjust for baseline covariates and presence of epileptiform abnormalities (seizures, periodic and rhythmic patterns).

Results

One hundred thirteen patients met the inclusion criteria; 39 (34.5%) were exposed to ASM. ASM treatment was not associated with 90-day mortality (propensity adjusted HR 1.0 [0.31–3.27], p = 0.999) or functional outcomes (adjusted HR 0.99 [0.32–3.02], p = 0.989), compared to no treatment.

Conclusions

In our study, ASM treatment in AIS patients with cEEG abnormalities was not significantly associated with a change in 90-day mortality and functional recovery. Larger comparative effectiveness studies are indicated to identify which acute ischemic stroke patients with cEEG abnormalities benefit most from ASM treatment.

Nur mit Berechtigung zugänglich

Dhakar M, Sheikh Z, Kumari P, Lawson E, Jeanneret V, Desai D, Rodriguez Ruiz A, Haider H (2020) Epileptiform abnormalities in acute ischemic stroke: impact on clinical management and outcomes. J Clin Neurophysiol. https://doi.org/10.1097/WNP.0000000000000801CrossRefPubMedPubMedCentral

Gavvala J et al (2014) Continuous EEG monitoring: a survey of neurophysiologists and neurointensivists. Epilepsia 55(11):1864–71. https://doi.org/10.1111/epi.12809CrossRefPubMed

Tabaeizadeh M et al (2020) Burden of epileptiform activity predicts discharge neurologic outcomes in severe acute ischemic stroke. Neurocrit Care. https://doi.org/10.1007/s12028-020-00944-0CrossRefPubMedPubMedCentral

Scoppettuolo P, Gaspard N, Depondt C, Legros B, Ligot N, Naeije G (2019) Epileptic activity in neurological deterioration after ischemic stroke, a continuous EEG study. Clin Neurophysiol. https://doi.org/10.1016/j.clinph.2019.09.005CrossRefPubMed

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349. https://doi.org/10.1371/journal.pmed.0040297CrossRef

Leung T, Leung H, Soo YOY, Mok VCT, Wong KS (2017) “The prognosis of acute symptomatic seizures after ischaemic stroke,” J. Neurol. Neurosurg. Psychiatry 88 (1) https://doi.org/10.1136/jnnp-2015-311849

Wang JZ, Vyas MV, Saposnik G, Burneo JG (2017) Incidence and management of seizures after ischemic stroke. Neurology 89(12):1220–1228. https://doi.org/10.1212/WNL.0000000000004407CrossRefPubMed

Westover MB et al (2015) The probability of seizures during EEG monitoring in critically ill adults. Clin Neurophysiol. https://doi.org/10.1016/j.clinph.2014.05.037CrossRefPubMedPubMedCentral

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. https://doi.org/10.1016/0021-9681(87)90171-8CrossRefPubMed

10.

Adams HP et al. (1999) “Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST),” Neurology 53 (1) https://doi.org/10.1212/WNL.53.1.126

11.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med. https://doi.org/10.1097/00003246-198510000-00009CrossRefPubMed

12.

B. B. Love and B. H. Bendixen (1993) “Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1. https://doi.org/10.1161/01.STR.24.1.35

13.

Hirsch LJ et al (2013) American Clinical Neurophysiology Society’s standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol 30(1):1–27. https://doi.org/10.1097/WNP.0b013e3182784729CrossRefPubMed

14.

De Marchis GM et al (2016) Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. https://doi.org/10.1212/WNL.0000000000002281CrossRefPubMedPubMedCentral

15.

Ruiz AR et al (2017) Association of periodic and rhythmic electroencephalographic patterns with seizures in critically ill patients. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2016.4990CrossRefPubMedPubMedCentral

16.

Quinn TJ, Dawson J, Walters MR, Lees KR (2009) “Functional outcome measures in contemporary stroke trials,” International Journal of Stroke 4 (3) https://doi.org/10.1111/j.1747-4949.2009.00271.x

17.

Galovic M et al (2018) Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study. Lancet Neurol. https://doi.org/10.1016/S1474-4422(17)30404-0CrossRefPubMed

18.

Fischer U et al. (2006) “Impact of comorbidity on ischemic stroke outcome,” Acta Neurol. Scand., 113 (2) https://doi.org/10.1111/j.1600-0404.2005.00551.x

19.

Mistry EA et al. (2017) “Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patients: a meta-analysis,” Stroke 48 (9) https://doi.org/10.1161/STROKEAHA.117.017320

20.

Moon BH, Park SK, Jang DK, Jang KS, Kim JT, Han YM (2015) Use of APACHE II and SAPS II to predict mortality for hemorrhagic and ischemic stroke patients. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2014.05.031CrossRefPubMed

21.

Rost NS et al (2016) Stroke severity is a crucial predictor of outcome: an international prospective validation study. J Am Heart Assoc. https://doi.org/10.1161/JAHA.115.002433CrossRefPubMedPubMedCentral

22.

Reith J, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS (1997) Seizures in acute stroke: predictors and prognostic significance: the Copenhagen Stroke Study. Stroke. https://doi.org/10.1161/01.STR.28.8.1585CrossRefPubMed

23.

Zafar SF et al (2021) Automated annotation of epileptiform burden and its association with outcomes. Ann Neurol 90(2):300–311. https://doi.org/10.1002/ana.26161CrossRefPubMedPubMedCentral

24.

Sivaraju A, Gilmore EJ (2016) Understanding and managing the ictal-interictal continuum in neurocritical care. Curr Treat Options Neurol 18(2):1–13. https://doi.org/10.1007/s11940-015-0391-0CrossRef

25.

Witsch J et al. (2017) “Electroencephalographic periodic discharges and frequency-dependent brain tissue hypoxia in acute brain injury,” JAMA Neurol., 74 (3) https://doi.org/10.1001/jamaneurol.2016.5325

26.

Vespa PM et al. (2007) “Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis,” Crit. Care Med 35 (12) https://doi.org/10.1097/01.CCM.0000295667.66853.BC

27.

Struck AF, Westover MB, Hall LT, Deck GM, Cole AJ, Rosenthal ES (2016) Metabolic correlates of the ictal-interictal continuum: FDG-PET during continuous EEG. Neurocrit Care. https://doi.org/10.1007/s12028-016-0245-yCrossRefPubMedPubMedCentral

28.

Punia V et al. (2021) “Long‐term continuation of anti‐seizure medications after acute stroke,” Ann. Clin. Transl. Neurol acn3.51440. https://doi.org/10.1002/acn3.51440

29.

Naidech AM et al (2005) Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. https://doi.org/10.1161/01.STR.0000141936.36596.1eCrossRefPubMed

30.

Yoon SJ, Joo JY, Kim YB, Hong CK, Chung J (2015) “Effects of prophylactic antiepileptic drugs on clinical outcomes in patients with a good clinical grade suffering from aneurysmal subarachnoid hemorrhage,” J. Cerebrovasc. Endovasc. Neurosurg 17 (3) https://doi.org/10.7461/jcen.2015.17.3.166

31.

Goldstein LB, Matchar DB, Morgenlander JC, Davis JN (1990) “Influence of drugs on the recovery of sensorimotor function after stroke,” Neurorehabil. Neural Repair 4 (3) https://doi.org/10.1177/136140969000400303

32.

Goldstein LB (1995) Common drugs may influence motor recovery after stroke. Neurology. https://doi.org/10.1212/WNL.45.5.865CrossRefPubMed

33.

Winter Y, Daneshkhah N, Galland N, Kotulla I, Krüger A, Groppa S (2018) Health-related quality of life in patients with poststroke epilepsy. Epilepsy Behav 80:303–306. https://doi.org/10.1016/j.yebeh.2017.12.037CrossRefPubMed

34.

Jones FJS et al (2021) Anticonvulsant primary and secondary prophylaxis for acute ischemic stroke patients: a decision analysis. Stroke. https://doi.org/10.1161/STROKEAHA.120.033299CrossRefPubMedPubMedCentral

35.

Punia V, Chandan P, Fesler J, Newey CR, Hantus S (2020) “Post-acute symptomatic seizure (PASS) clinic: a continuity of care model for patients impacted by continuous EEG monitoring,” Epilepsia Open 5 (2) https://doi.org/10.1002/epi4.12393

36.

Herman ST et al (2015) Consensus statement on continuous EEG in critically Ill adults and children, part I: indications. J Clin Neurophysiol. https://doi.org/10.1097/WNP.0000000000000166CrossRefPubMedPubMedCentral

37.

Benbadis SR, Chen S, Melo M (2010) “Whats shaking in the ICU? The differential diagnosis of seizures in the intensive care setting,” Epilepsia 51 (11) https://doi.org/10.1111/j.1528-1167.2010.02683.x

38.

Boesebeck F, Freermann S, Kellinghaus C, Evers S (2010) “Misdiagnosis of epileptic and non-epileptic seizures in a neurological intensive care unit,” Acta Neurol. Scand 122 (3) https://doi.org/10.1111/j.1600-0404.2009.01287.x

Titel: Anti-seizure medication treatment and outcomes in acute ischemic stroke patients undergoing continuous EEG monitoring
verfasst von: Paula R. Sanches
Mohammad Tabaeizadeh
Lidia M. V. R. Moura
Eric S. Rosenthal
Luis Otavio Caboclo
John Hsu
Elisabetta Patorno
M. Brandon Westover
Sahar F. Zafar
Publikationsdatum: 17.06.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 9/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06183-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2022

Development of an Italian version of the functional communication measures and preliminary observations in patients with severe acquired brain injury and emerging from a prolonged disorder of consciousness

Episodic memory in progressive supranuclear palsy: a neuropsychological and neuroimaging study

Sport and migraine—a dynamic relationship

The first report of the Italian Migraine Registry (I-GRAINE)

The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine